Impax Laboratories Inc. (IPXL) Sank To A New Low After Q4 Report

Impax Laboratories Inc. (IPXL) reported fourth quarter adjusted EPS of $0.16 Wednesday morning, down from $0.62 in the previous year. The consensus estimate was for EPS of $0.16.

from RTT - Before the Bell http://ift.tt/2mOvBom
via IFTTT